These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20627700)

  • 1. Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiency.
    Freiberger T; Grodecká L; Ravcuková B; Kurecová B; Postránecká V; Vlcek J; Jarkovský J; Thon V; Litzman J
    Clin Immunol; 2010 Sep; 136(3):419-25. PubMed ID: 20627700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association of FCRN promoter VNTR polymorphism with the rate of maternal-fetal IgG transfer.
    Freiberger T; Ravcuková B; Grodecká L; Kurecová B; Jarkovský J; Bartonková D; Thon V; Litzman J
    J Reprod Immunol; 2010 Jun; 85(2):193-7. PubMed ID: 20452034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of FCRN expression on lung decline and intravenous immunoglobulin catabolism in common variable immunodeficiency patients.
    Litzman J
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):103-4. PubMed ID: 25546780
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors.
    Gregersen S; Aaløkken TM; Mynarek G; Fevang B; Holm AM; Ueland T; Aukrust P; Kongerud J; Johansen B; Frøland SS
    Ann Allergy Asthma Immunol; 2010 Jun; 104(6):503-10. PubMed ID: 20568383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.
    Gouilleux-Gruart V; Chapel H; Chevret S; Lucas M; Malphettes M; Fieschi C; Patel S; Boutboul D; Marson MN; Gérard L; Lee M; Watier H; Oksenhendler E;
    Clin Exp Immunol; 2013 Feb; 171(2):186-94. PubMed ID: 23286945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy.
    Vlam L; Cats EA; Willemse E; Franssen H; Medic J; Piepers S; Veldink JH; van den Berg LH; van der Pol WL
    J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1145-8. PubMed ID: 24336791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy.
    Horn J; Thon V; Bartonkova D; Salzer U; Warnatz K; Schlesier M; Peter HH; Grimbacher B
    Clin Immunol; 2007 Feb; 122(2):156-62. PubMed ID: 17137841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IgG subclass concentrations before and after administration of intravenous immunoglobulin in common variable immunodeficiency.
    Ozawa T; Motoyoshi F; Kato Y; Kondo N; Orii T
    J Clin Lab Immunol; 1992; 38(1):29-39. PubMed ID: 1343346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies.
    Bayry J; Fournier EM; Maddur MS; Vani J; Wootla B; Sibéril S; Dimitrov JD; Lacroix-Desmazes S; Berdah M; Crabol Y; Oksenhendler E; Lévy Y; Mouthon L; Sautès-Fridman C; Hermine O; Kaveri SV
    J Autoimmun; 2011 Feb; 36(1):9-15. PubMed ID: 20970960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.
    Wasserman RL; Church JA; Peter HH; Sleasman JW; Melamed I; Stein MR; Bichler J;
    Eur J Pharm Sci; 2009 Jun; 37(3-4):272-8. PubMed ID: 19491015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency.
    Baris S; Ercan H; Cagan HH; Ozen A; Karakoc-Aydiner E; Ozdemir C; Bahceciler NN
    J Investig Allergol Clin Immunol; 2011; 21(7):514-21. PubMed ID: 22312934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of the bovine FcRn in the mammary gland results in increased IgG levels in both milk and serum of transgenic mice.
    Lu W; Zhao Z; Zhao Y; Yu S; Zhao Y; Fan B; Kacskovics I; Hammarström L; Li N
    Immunology; 2007 Nov; 122(3):401-8. PubMed ID: 17608809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunological features of common variable immunodeficiency in Mexican patients.
    Ramírez-Vargas N; Arablin-Oropeza SE; Mojica-Martínez D; Yamazaki-Nakashimada MA; de la Luz García-Cruz M; Terán-Juárez LM; Cortés-Grimaldo RM; Torres-Lozano C; Madrigal-Beas I; Ortega-Cisneros M; Vargas-Camaño ME; Staines-Boone T; Pietropaolo-Cienfuegos D; Berrón-Ruiz L; Espinosa-Rosales FJ; Guevara-Cruz M; Blancas-Galicia L
    Allergol Immunopathol (Madr); 2014; 42(3):235-40. PubMed ID: 23578780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor alpha-chain promoter.
    Sachs UJ; Socher I; Braeunlich CG; Kroll H; Bein G; Santoso S
    Immunology; 2006 Sep; 119(1):83-9. PubMed ID: 16805790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.
    Oksenhendler E
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):92-3. PubMed ID: 25546776
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia.
    Aghamohammadi A; Allahverdi A; Abolhassani H; Moazzami K; Alizadeh H; Gharagozlou M; Kalantari N; Sajedi V; Shafiei A; Parvaneh N; Mohammadpour M; Karimi N; Sadaghiani MS; Rezaei N
    Respirology; 2010 Feb; 15(2):289-95. PubMed ID: 20051045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease.
    Mullighan CG; Fanning GC; Chapel HM; Welsh KI
    J Immunol; 1997 Dec; 159(12):6236-41. PubMed ID: 9550427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of dimeric peptide antagonists of the human immunoglobulin G-human neonatal Fc receptor (IgG-FcRn) interaction.
    McDonnell KA; Low SC; Hoehn T; Donnelly R; Palmieri H; Fraley C; Sakorafas P; Mezo AR
    J Med Chem; 2010 Feb; 53(4):1587-96. PubMed ID: 20092334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.
    Lucas M; Lee M; Lortan J; Lopez-Granados E; Misbah S; Chapel H
    J Allergy Clin Immunol; 2010 Jun; 125(6):1354-1360.e4. PubMed ID: 20471071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Personal experience with replacement therapy with intravenous gamma globulin].
    Litzman J; Lokaj J; Stikarovská D; Mayer J; Thon V; Eibl MM
    Vnitr Lek; 1995 Nov; 41(11):759-63. PubMed ID: 8553594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.